Efficacy of convalescent plasma for treatment of COVID-19 in Uganda

B Kirenga, P Byakika-Kibwika… - BMJ open …, 2021 - bmjopenrespres.bmj.com
Rationale Convalescent plasma (CCP) has been studied as a potential therapy for COVID-19,
but data on its efficacy in Africa are limited. Objective In this trial we set out to determine …

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults

P Byakika-Kibwika, M Lamorde, J Mayito… - Journal of …, 2012 - academic.oup.com
Objectives Co-administration of artemether/lumefantrine with antiretroviral therapy has potential
for pharmacokinetic drug interactions. We investigated drug–drug interactions between …

Medicinal plants used by traditional medicine practitioners for the treatment of HIV/AIDS and related conditions in Uganda

…, H Lanyero, P Byakika-Kibwika… - Journal of …, 2010 - Elsevier
INTRODUCTION AND OBJECTIVES: In Uganda, there are over one million people with HIV/AIDS.
When advanced, this disease is characterized by life-threatening opportunistic …

Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults

P Byakika-Kibwika, M Lamorde… - Journal of …, 2012 - academic.oup.com
Background Treatment of HIV/malaria-coinfected patients with antiretroviral therapy (ART)
and artemisinin-based combination therapy has potential for drug interactions. We …

COVID-19 vaccine acceptance among high-risk populations in Uganda

…, M Kaddumukasa, P Byakika-Kibwika… - Therapeutic …, 2021 - journals.sagepub.com
Background: Immunization is an important strategy for controlling the COVID-19 pandemic.
COVID-19 vaccination was recently launched in Uganda, with prioritization to healthcare …

Mentorship needs at academic institutions in resource-limited settings: a survey at Makerere University College of Health Sciences

D Nakanjako, P Byakika-Kibwika, K Kintu, J Aizire… - BMC medical …, 2011 - Springer
Pauline Byakika-Kibwika. In addition, the authors acknowledge the administrative staff of
the Uganda Society for health sciences (Richard Senvewo and Isabella Achokotho) for their …

Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm …

…, DJ Back, P Byakika-Kibwika… - Clinical Infectious …, 2016 - academic.oup.com
Background. Levonorgestrel subdermal implants are preferred contraceptives with an
expected failure rate of <1% over 5 years. We assessed the effect of efavirenz- or nevirapine-…

Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults

P Byakika-Kibwika, M Lamorde, J Mayito, L Nabukeera… - Malaria journal, 2012 - Springer
Background Severe malaria is a medical emergency with high mortality. Prompt achievement
of therapeutic concentrations of highly effective anti-malarial drugs reduces the risk of …

[HTML][HTML] Bacteremia among febrile Ugandan children treated with antimalarials despite a negative malaria test

A Kibuuka, P Byakika-Kibwika, J Achan… - The American journal …, 2015 - ncbi.nlm.nih.gov
Bacteremia may be inappropriately treated as malaria in children admitted with a febrile
illness in Africa. We determined the prevalence, clinical features, and spectrum of bacteremia …

Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial

P Byakika-Kibwika, C Sekaggya-Wiltshire… - BMC Infectious …, 2021 - Springer
Background Several repurposed drugs such as hydroxychloroquine (HCQ) have been
investigated for treatment of COVID-19, but none was confirmed to be efficacious. While in vitro …